David F. Allison
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 5
- Epigenetics and DNA Methylation 4
- Histone Deacetylase Inhibitors Research 3
- DNA Repair Mechanisms 2
- CRISPR and Genetic Engineering 2
- Ubiquitin and proteasome pathways 2
- Wnt/β-catenin signaling in development and cancer 2
- Cell Biology top 5%
- Immunology and Allergy top 10%
- Cancer Research top 10%
- Hematology top 10%
-
- Cancer Cells and Metastasis 3
- Co-authors
- Gang Greg WangVictor FaúndezAndrew P. KowalczykPeter VincentKathleen M. BuckleyMarty W. MayoDavid R. JonesLing Cai
- Partner nations
- United StatesTaiwanUkraine
In The Last Decade
David F. Allison
15 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 93
- Molecular Biology 1.2k
- Cell Biology 255
- Immunology and Allergy 83
- Cancer Research 203
- Hematology 115
Countries citing papers authored by David F. Allison
This map shows the geographic impact of David F. Allison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David F. Allison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David F. Allison more than expected).
Fields of papers citing papers by David F. Allison
This network shows the impact of papers produced by David F. Allison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David F. Allison. The network helps show where David F. Allison may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David F. Allison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 119 | |
| 3 | 2020 | 67 | |
| 4 | 2019 | 47 | |
| 5 | 2019 | 88 | |
| 6 | 2019 | 52 | |
| 7 | 2018 | 31 | |
| 8 | 2015 | 79 | |
| 9 | 2014 | 61 | |
| 10 | 2014 | 12 | |
| 11 | 2014 | 173 | |
| 12 | 2013 | 38 | |
| 13 | 2013 | 93 | |
| 14 | 2012 | 96 | |
| 15 | 2003 | 129 | |
| 16 | 2003 | 345 |
About David F. Allison
David F. Allison is a scholar working on Cancer Research, Geriatrics and Gerontology and Molecular Biology, having authored 16 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (5 papers), Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (3 papers), Histone Deacetylase Inhibitors Research (3 papers), DNA Repair Mechanisms (2 papers), CRISPR and Genetic Engineering (2 papers), Ubiquitin and proteasome pathways (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Cell Biology (255 citations) and Immunology and Allergy (83 citations). David F. Allison has collaborated with scholars based in United States, Taiwan and Ukraine. Frequent co-authors include Gang Greg Wang, Victor Faúndez, Andrew P. Kowalczyk, Peter Vincent, Kathleen M. Buckley, Marty W. Mayo, David R. Jones, Ling Cai, Stefan Bekiranov and Anqi Ma. Their work appears in journals such as Blood, The Journal of Cell Biology, Nature Genetics, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.